Glucagon-like peptide-1 improves betacell response to glucose in subjects with impaired glucose tolerance

Details for Australian Patent Application No. 2003212050 (hide)

International Classifications

Event Publications

24 July 2003 Complete Application Filed

14 August 2003 Application Open to Public Inspection

Published as AU-B-2003212050

27 November 2003 Assignment before Grant

BioNebraska, Inc. The application has been assigned to Amylin Pharmaceuticals, Inc.

16 February 2006 Application Accepted

Published as AU-B-2003212050

15 June 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.